CADL Earnings

Quarterly EPS
$-0.33
Q3 2024
$-0.40
Q4 2024
$0.15
Q1 2025
$-0.09
Q2 2025
$-0.21
Q3 2025
$-0.54
Q4 2025
$-0.14
Q1 2026
$-0.52
Q2 2026
Latest RevenueN/A
Latest Net Income-38927000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.520-38927000-477.8%
Q1 2026-$0.140-8861000-193.3%
Q4 2025-$0.540-29496000-35.0%
Q3 2025-$0.210-11269000+36.4%
Q2 2025-$0.090-4796000+87.8%
Q1 2025$0.1507.4M+153.6%
Q4 2024-$0.400-14073000-5.3%
Q3 2024-$0.330-10646000-13.8%
Q2 2024-$0.740-22237000
Q1 2024-$0.280-8221000
Q4 2023-$0.380-11095000
Q3 2023-$0.290-8435000
Candel Therapeutics (CADL) — Earnings